Literature DB >> 11432964

A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.

F Tassone1, R J Hagerman, A K Taylor, P J Hagerman.   

Abstract

FMR1 mRNA levels were determined in peripheral blood leucocytes for 48 fragile X males with methylated, full mutation alleles that are resistant to cleavage by methylation sensitive enzymes. Using quantitative (fluorescence) RT-PCR, we observed that more than half of these males produce FMR1 mRNA, with some mRNA levels approaching those found in normal subjects. In none of the samples analysed was there any evidence of premutation alleles. These results suggest that the assumed relationship between enzyme resistance and FMR1 gene silencing may not be generally valid. Despite the presence of FMR1 mRNA in some subjects, no FMRP production was detected by either immunocytochemistry or western blotting. The low/absent FMRP levels are probably a reflection of a post-trancriptional effect such as a defect in translation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432964      PMCID: PMC1757182          DOI: 10.1136/jmg.38.7.453

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  41 in total

1.  In sickness and in health: the importance of translational regulation.

Authors:  P R Reynolds
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  Destabilization of tetraplex structures of the fragile X repeat sequence (CGG)n is mediated by homolog-conserved domains in three members of the hnRNP family.

Authors:  Samer Khateb; Pnina Weisman-Shomer; Inbal Hershco; Lawrence A Loeb; Michael Fry
Journal:  Nucleic Acids Res       Date:  2004-08-09       Impact factor: 16.971

Review 3.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

4.  Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice.

Authors:  Mathilde Renaud; Julien Perriard; Sarah Coudray; Mathieu Sévin-Allouet; Christophe Marcel; Wassilios G Meissner; Jean-Baptiste Chanson; Nicolas Collongues; Nathalie Philippi; Odile Gebus; Véronique Quenardelle; Anna Castrioto; Paul Krack; Karine N'Guyen; François Lefebvre; Andoni Echaniz-Laguna; Jean-Philippe Azulay; Nicolas Meyer; Pierre Labauge; Christine Tranchant; Mathieu Anheim
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

Review 5.  Advances in understanding the molecular basis of FXTAS.

Authors:  Dolores Garcia-Arocena; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2010-04-29       Impact factor: 6.150

6.  Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders.

Authors:  Michael R Hunsaker; Claudia M Greco; Flora Tassone; Robert F Berman; Rob Willemsen; Randi J Hagerman; Paul J Hagerman
Journal:  J Neuropathol Exp Neurol       Date:  2011-06       Impact factor: 3.685

7.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

8.  5'-UTR SNP of FGF13 causes translational defect and intellectual disability.

Authors:  Xingyu Pan; Jingrong Zhao; Zhiying Zhou; Jijun Chen; Zhenxing Yang; Yuxuan Wu; Meizhu Bai; Yang Jiao; Yun Yang; Xuye Hu; Tianling Cheng; Qianyun Lu; Bin Wang; Chang-Lin Li; Ying-Jin Lu; Lei Diao; Yan-Qing Zhong; Jing Pan; Jianmin Zhu; Hua-Sheng Xiao; Zi-Long Qiu; Jinsong Li; Zefeng Wang; Jingyi Hui; Lan Bao; Xu Zhang
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

9.  Aging in individuals with the FMR1 mutation.

Authors:  S Jacquemont; F Farzin; D Hall; M Leehey; F Tassone; L Gane; L Zhang; J Grigsby; T Jardini; F Lewin; E Berry-Kravis; P J Hagerman; R J Hagerman
Journal:  Am J Ment Retard       Date:  2004-03

10.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.